– Dow Jones Citing WSJ
Related Posts
Keefe, Bruyette & Woods Downgrades Hercules Capital to Underperform, Lowers Price Target to $10.5
Keefe, Bruyette & Woods analyst Ryan Lynch downgrades Hercules Capital (NYSE:HTGC) from Market Perform to Underperform and lowers the price target from $14.5 to $10.5.
Truist Securities Maintains Buy on Costco Wholesale, Raises Price Target to $568
Truist Securities analyst Scot Ciccarelli maintains Costco Wholesale (NASDAQ:COST) with a Buy and raises the price target from $538 to $568.
FDA Accepts For Priority Review Ascendis Pharma’s NDA For TransCon™ PTH In Adult Patients With Hypoparathyroidism
Ascendis Pharma A/S (NASDAQ:ASND) today announced that the U.S. Food & Drug Administration (FDA) has accepted for Priority Review its New Drug Application (NDA) for TransCon PTH (palopegteriparatide) in adult